Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.
Mainly for the treatment of urinary tract infections such as cystitis, urethritis.
This report contains market size and forecasts of Fosfomycin Trometamol in global, including the following market information:
Global Fosfomycin Trometamol Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Fosfomycin Trometamol Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Fosfomycin Trometamol companies in 2021 (%)
The global Fosfomycin Trometamol market was valued at 33 million in 2021 and is projected to reach US$ 40 million by 2028, at a CAGR of 2.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Fosfomycin Tromethamine Granules Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fosfomycin Trometamol include Zambon, Northesat Pharm, Hunan Huana Pharmaceuticals, Xunda Pharma, FarmaSino Pharmaceutical and Guilin Hwasun, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fosfomycin Trometamol manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fosfomycin Trometamol Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Fosfomycin Trometamol Market Segment Percentages, by Type, 2021 (%)
Fosfomycin Tromethamine Granules
Fosfomycin Tromethamine Powder
Global Fosfomycin Trometamol Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Fosfomycin Trometamol Market Segment Percentages, by Application, 2021 (%)
Common Urinary Tract Infection
Postoperative Urinary Tract Infection
Preoperative Prevention of Urinary Tract Infection
Others
Global Fosfomycin Trometamol Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Fosfomycin Trometamol Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fosfomycin Trometamol revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Fosfomycin Trometamol revenues share in global market, 2021 (%)
Key companies Fosfomycin Trometamol sales in global market, 2017-2022 (Estimated), (MT)
Key companies Fosfomycin Trometamol sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zambon
Northesat Pharm
Hunan Huana Pharmaceuticals
Xunda Pharma
FarmaSino Pharmaceutical
Guilin Hwasun